Quince Therapeutics Amends Articles of Incorporation
Ticker: QNCX · Form: 8-K · Filed: Apr 9, 2026 · CIK: 0001662774
| Field | Detail |
|---|---|
| Company | Quince Therapeutics, Inc. (QNCX) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, amendment
Related Tickers: QNCE
TL;DR
Quince Therapeutics (QNCE) filed an 8-K on 4/9/26 to amend its Articles of Incorporation.
AI Summary
On April 9, 2026, Quince Therapeutics, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation. These amendments, filed under Item 5.03, signify changes to the company's foundational governing documents.
Why It Matters
Amendments to Articles of Incorporation can alter a company's structure, governance, or shareholder rights, potentially impacting its strategic direction and investor relations.
Risk Assessment
Risk Level: low — This filing pertains to administrative changes in corporate governance documents and does not immediately indicate significant financial or operational risks.
Key Players & Entities
- Quince Therapeutics, Inc. (company) — Filer of the 8-K report
- 0001662774 (company) — CIK number for Quince Therapeutics, Inc.
- 2026-04-09 (date) — Filing date of the 8-K report
FAQ
What specific items were amended in Quince Therapeutics' Articles of Incorporation?
The filing indicates amendments under Item 5.03, which covers Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Specific details of the amendments are not provided in the summary but would be found within the referenced exhibits.
What is the CIK number for Quince Therapeutics, Inc.?
The CIK number for Quince Therapeutics, Inc. is 0001662774.
When was this 8-K filing accepted by the SEC?
The 8-K filing was accepted on April 9, 2026, at 09:23:02.
What are the business and mailing addresses for Quince Therapeutics, Inc.?
Both the business and mailing addresses for Quince Therapeutics, Inc. are listed as 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080.
What SIC code is associated with Quince Therapeutics, Inc.?
Quince Therapeutics, Inc. is associated with SIC code 2836, which pertains to Biological Products, (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2026 regarding Quince Therapeutics, Inc. (QNCX).